Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novo Nordisk Cuts 400 Jobs In R&D Reshuffle As It Broadens Its Horizons

Sep 18 2018

• By Mandy Jackson

Business reengineering

Related Content

Novo Nordisk Grabs Shark Antibody-Based CNS Delivery Technology From Ossianix

Sep 04 2018

Novo Nordisk Makes Long-Term Bet On GBM Technology With Ziylo Buy

Aug 17 2018

Evotec's CEO Explains Logic Behind Drug Discovery Pact With Novo Nordisk

Aug 23 2018

Seeking Efficiencies, Novo Nordisk To Squeeze Costs, Boost Growth Drivers

Aug 08 2018

Novo To Secure Licensing Or M&A Deal By Mid-2018

Feb 01 2018

"Take More Risks, Fail Earlier" Says Asset-Hunting Novo Nordisk CEO

Mar 07 2018

With Novo Nordisk Dependent On GLP-1s, Even Perceived Price Pressures Can Hurt

Aug 09 2018

Related Companies

Novo Nordisk A/S

Ablynx N.V.

Sanofi

Ossianix Inc.

Evotec SE

Additional Topics

Business Strategies Companies Deals Commercial BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window